Optimized thiopurine therapy before withdrawal of anti-tumour necrosis factor-α in patients with Crohn's disease

Keyphrases

• Crohn's Disease 100%
• Anti-tumor Necrosis Factor (anti-TNF) 100%
• Thiopurine Therapy 100%
• Remission 40%
• Disease Duration 40%
• Fecal Calprotectin 40%
• Meta-analysis 20%
• First Year 20%
• Relapse Rate 20%
• Hemoglobin 20%
• Relapse Risk 20%
• Red Blood Cells 20%
• Anti-tumor Necrosis Factor Therapy 20%
• Calprotectin 20%
• Harvey-Bradshaw Index 20%
• 6-Thioguanine (6-TG) 20%
• Biochemical Relapse 20%

Pharmacology, Toxicology and Pharmaceutical Science

• Crohn's Disease 100%
• Tumor Necrosis 100%
• Mercaptopurine 100%
• Remission 50%
• Calgranulin 50%
• Disease Duration 33%
• Observational Study 16%
• Recurrence Risk 16%
• Tioguanine 16%